A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma Meeting Abstract
| Authors: | Slotkin, E. K.; Mauguen, A.; Ortiz, M. V.; Dela Cruz, F. S.; O'Donohue, T.; Kinnaman, M. D.; Meyers, P. A.; Wexler, L. H.; Rodriguez, S.; Avutu, V.; Kelly, C. M.; D'Angelo, S. P.; Keohan, M. L.; Gounder, M. M.; Nacev, B. A.; Rosenbaum, E.; Dickson, M. A.; Thornton, K. A.; Bender, J. L. G.; Tap, W. D. |
| Abstract Title: | A phase I/II study of prexasertib in combination with irinotecan in patients with relapsed/refractory desmoplastic small round cell tumor and rhabdomyosarcoma |
| Meeting Title: | 2022 ASCO Annual Meeting |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 40 |
| Issue: | 16 Suppl. |
| Meeting Dates: | 2022 Jun 3-7 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2022-06-01 |
| Language: | English |
| ACCESSION: | WOS:000863680300345 |
| PROVIDER: | wos |
| DOI: | 10.1200/JCO.2022.40.16_suppl.11503 |
| Notes: | Meeting Abstract: 11503 -- Meeting also held virtually -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
